Introduction Pulmonary hypertension in infants is characterized by elevated pulmonary vascular resistance which leads to right-to-left shunting of deoxygenated blood across the ductus arteriosus and foramen ovale into the systemic circulation leading to hypoxemia. It is associated with significant morbidity and the mortality rate has been reported to be between 7 and 15%, which is increased particularly in infants with congenital diaphragmatic hernia (CDH) or bronchopulmonary dysplasia (BPD).

Angeline Darren

Christopher Harris

Anne Greenough

Expert Opinion on Orphan Drugs

EXPERT OPINION ON ORPHAN DRUGS 是一本经过同行评审的国际期刊，涵盖了罕见病和孤儿药研发的各个方面。

Expert Opinion on Orphan Drugs is a peer-reviewed international journal that focuses on the research and development of orphan drugs and rare diseases, covering various aspects of the field.

《Expert Opinion on Orphan Drugs》是一本经过同行评审的国际期刊，专注于罕见病和孤儿药的研发，涵盖了相关领域的各个方面。

Category	Quartile
医学	4
医学, 药学	4

Management of pulmonary hypertension in infants

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info

Category	Quartile
PHARMACOLOGY & PHARMACY	4